Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Structural and functional disconnections convey the pathology progression along the Alzheimer's continuum.

Filippi M, Basaia S, Canu E, Imperiale F, Magnani G, Falautano M, Comi G, Falini A, Agosta F.

Mol Psychiatry. 2020 Jan;25(1):1. doi: 10.1038/s41380-019-0612-0. No abstract available.

PMID:
31827244
2.

Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant.

Caso F, Canu E, Lukic MJ, Petrovic IN, Fontana A, Nikolic I, Kostic VS, Filippi M, Agosta F.

J Neurol. 2019 Sep 26. doi: 10.1007/s00415-019-09555-y. [Epub ahead of print]

PMID:
31559533
3.

Northwestern Anagram Test-Italian (Nat-I) for primary progressive aphasia.

Canu E, Agosta F, Imperiale F, Ferraro PM, Fontana A, Magnani G, Mesulam MM, Thompson CK, Weintraub S, Moro A, Cappa SF, Filippi M.

Cortex. 2019 Oct;119:497-510. doi: 10.1016/j.cortex.2019.08.007. Epub 2019 Aug 21.

PMID:
31527011
4.

Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.

Ayer AH, Wojta K, Ramos EM, Dokuru D, Chen JA, Karydas AM, Papatriantafyllou JD, Agiomyrgiannakis D, Kamtsadeli V, Tsinia N, Sali D, Gylys KH, Agosta F, Filippi M, Small GW, Bennett DA, Gearing M, Juncos JL, Kramer J, Lee SE, Yokoyama JS, Mendez MF, Chui H, Zarow C, Ringman JM, Kilic U, Babacan-Yildiz G, Levey A, DeCarli CS, Cotman CW, Boxer AL, Miller BL, Coppola G.

Alzheimer Dis Assoc Disord. 2019 Oct-Dec;33(4):327-330. doi: 10.1097/WAD.0000000000000339.

PMID:
31513029
5.

Resting State Dynamic Functional Connectivity in Neurodegenerative Conditions: A Review of Magnetic Resonance Imaging Findings.

Filippi M, Spinelli EG, Cividini C, Agosta F.

Front Neurosci. 2019 Jun 20;13:657. doi: 10.3389/fnins.2019.00657. eCollection 2019. Review.

6.

10Kin1day: A Bottom-Up Neuroimaging Initiative.

van den Heuvel MP, Scholtens LH, van der Burgh HK, Agosta F, Alloza C, Arango C, Auyeung B, Baron-Cohen S, Basaia S, Benders MJNL, Beyer F, Booij L, Braun KPJ, Filho GB, Cahn W, Cannon DM, Chaim-Avancini TM, Chan SSM, Chen EYH, Crespo-Facorro B, Crone EA, Dannlowski U, de Zwarte SMC, Dietsche B, Donohoe G, Plessis SD, Durston S, Díaz-Caneja CM, Díaz-Zuluaga AM, Emsley R, Filippi M, Frodl T, Gorges M, Graff B, Grotegerd D, Gąsecki D, Hall JM, Holleran L, Holt R, Hopman HJ, Jansen A, Janssen J, Jodzio K, Jäncke L, Kaleda VG, Kassubek J, Masouleh SK, Kircher T, Koevoets MGJC, Kostic VS, Krug A, Lawrie SM, Lebedeva IS, Lee EHM, Lett TA, Lewis SJG, Liem F, Lombardo MV, Lopez-Jaramillo C, Margulies DS, Markett S, Marques P, Martínez-Zalacaín I, McDonald C, McIntosh AM, McPhilemy G, Meinert SL, Menchón JM, Montag C, Moreira PS, Morgado P, Mothersill DO, Mérillat S, Müller HP, Nabulsi L, Najt P, Narkiewicz K, Naumczyk P, Oranje B, Ortiz-Garcia de la Foz V, Peper JS, Pineda JA, Rasser PE, Redlich R, Repple J, Reuter M, Rosa PGP, Ruigrok ANV, Sabisz A, Schall U, Seedat S, Serpa MH, Skouras S, Soriano-Mas C, Sousa N, Szurowska E, Tomyshev AS, Tordesillas-Gutierrez D, Valk SL, van den Berg LH, van Erp TGM, van Haren NEM, van Leeuwen JMC, Villringer A, Vinkers CH, Vollmar C, Waller L, Walter H, Whalley HC, Witkowska M, Witte AV, Zanetti MV, Zhang R, de Lange SC.

Front Neurol. 2019 May 9;10:425. doi: 10.3389/fneur.2019.00425. eCollection 2019.

7.

Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72.

Falzone YM, Radaelli M, Agosta F, Domi T, Guerrieri S, Spinelli EG, Pozzi L, Carrera P, Ferrari M, Comi G, Filippi M, Quattrini A, Riva N.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):449-452. doi: 10.1080/21678421.2019.1604761. Epub 2019 Apr 22.

PMID:
31007077
8.

Brain MRI shows white matter sparing in Kennedy's disease and slow-progressing lower motor neuron disease.

Spinelli EG, Agosta F, Ferraro PM, Querin G, Riva N, Bertolin C, Martinelli I, Lunetta C, Fontana A, Sorarù G, Filippi M.

Hum Brain Mapp. 2019 Jul;40(10):3102-3112. doi: 10.1002/hbm.24583. Epub 2019 Mar 28.

PMID:
30924230
9.

Crossed aphasia confirmed by fMRI in a case with nonfluent variant of primary progressive aphasia carrying a GRN mutation.

Canu E, Bessi V, Leocadi M, Padiglioni S, Nacmias B, Sorbi S, Filippi M, Agosta F.

J Neurol. 2019 May;266(5):1274-1279. doi: 10.1007/s00415-019-09298-w. Epub 2019 Mar 29.

PMID:
30923936
10.

Survival prediction models in motor neuron disease.

Agosta F, Spinelli EG, Riva N, Fontana A, Basaia S, Canu E, Castelnovo V, Falzone Y, Carrera P, Comi G, Filippi M.

Eur J Neurol. 2019 Sep;26(9):1143-1152. doi: 10.1111/ene.13957. Epub 2019 Apr 20.

PMID:
30920076
11.

White Matter Microstructure Breakdown in the Motor Neuron Disease Spectrum: Recent Advances Using Diffusion Magnetic Resonance Imaging.

Basaia S, Filippi M, Spinelli EG, Agosta F.

Front Neurol. 2019 Mar 5;10:193. doi: 10.3389/fneur.2019.00193. eCollection 2019. Review.

12.

Resting-state Functional MRI in Parkinsonian Syndromes.

Filippi M, Sarasso E, Agosta F.

Mov Disord Clin Pract. 2019 Feb 8;6(2):104-117. doi: 10.1002/mdc3.12730. eCollection 2019 Feb. Review.

PMID:
30838308
13.

Can action observation modulate balance performance in healthy subjects?

Gatti R, Sarasso E, Pelachin M, Agosta F, Filippi M, Tettamanti A.

Arch Physiother. 2019 Jan 22;9:1. doi: 10.1186/s40945-018-0053-0. eCollection 2019.

14.

Added value of multimodal MRI to the clinical diagnosis of primary progressive aphasia variants.

Canu E, Agosta F, Imperiale F, Fontana A, Caso F, Spinelli EG, Magnani G, Falini A, Comi G, Filippi M.

Cortex. 2019 Apr;113:58-66. doi: 10.1016/j.cortex.2018.11.025. Epub 2018 Dec 8.

PMID:
30605869
15.

Automated classification of Alzheimer's disease and mild cognitive impairment using a single MRI and deep neural networks.

Basaia S, Agosta F, Wagner L, Canu E, Magnani G, Santangelo R, Filippi M; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2019;21:101645. doi: 10.1016/j.nicl.2018.101645. Epub 2018 Dec 18.

16.

Functional MRI in Atypical Parkinsonisms.

Agosta F, Sarasso E, Filippi M.

Int Rev Neurobiol. 2018;142:149-173. doi: 10.1016/bs.irn.2018.09.002. Epub 2018 Oct 25. Review.

PMID:
30409252
17.

Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-centre tract of interest-based DTI analysis.

Müller HP, Agosta F, Gorges M, Kassubek R, Spinelli EG, Riva N, Ludolph AC, Filippi M, Kassubek J.

Neuroimage Clin. 2018;20:1062-1069. doi: 10.1016/j.nicl.2018.10.005. Epub 2018 Oct 9.

18.

Functional MRI in Idiopathic Parkinson's Disease.

Filippi M, Elisabetta S, Piramide N, Agosta F.

Int Rev Neurobiol. 2018;141:439-467. doi: 10.1016/bs.irn.2018.08.005. Epub 2018 Aug 24. Review.

PMID:
30314606
19.

Are there two different forms of functional dystonia? A multimodal brain structural MRI study.

Tomic A, Agosta F, Sarasso E, Petrovic I, Basaia S, Pesic D, Kostic M, Fontana A, Kostic VS, Filippi M.

Mol Psychiatry. 2018 Aug 17. doi: 10.1038/s41380-018-0222-2. [Epub ahead of print]

PMID:
30120414
20.

Functional and structural brain networks in posterior cortical atrophy: A two-centre multiparametric MRI study.

Agosta F, Mandic-Stojmenovic G, Canu E, Stojkovic T, Imperiale F, Caso F, Stefanova E, Copetti M, Kostic VS, Filippi M.

Neuroimage Clin. 2018 Jun 12;19:901-910. doi: 10.1016/j.nicl.2018.06.013. eCollection 2018.

21.

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus.

Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Neurol. 2018 Oct;25(10):1201-1217. doi: 10.1111/ene.13728. Epub 2018 Jul 20.

PMID:
29932266
22.

Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.

Walker Z, Gandolfo F, Orini S, Garibotto V, Agosta F, Arbizu J, Bouwman F, Drzezga A, Nestor P, Boccardi M, Altomare D, Festari C, Nobili F; EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1534-1545. doi: 10.1007/s00259-018-4031-2. Epub 2018 May 19. Review.

23.

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.

Drzezga A, Altomare D, Festari C, Arbizu J, Orini S, Herholz K, Nestor P, Agosta F, Bouwman F, Nobili F, Walker Z, Frisoni GB, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1487-1496. doi: 10.1007/s00259-018-4032-1. Epub 2018 May 13. Review.

PMID:
29756163
24.

Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Ferraro PM, Jester C, Olm CA, Placek K, Agosta F, Elman L, McCluskey L, Irwin DJ, Detre JA, Filippi M, Grossman M, McMillan CT.

Neurobiol Aging. 2018 Aug;68:85-92. doi: 10.1016/j.neurobiolaging.2018.04.008. Epub 2018 Apr 17.

25.

MRI of non-Alzheimer's dementia: current and emerging knowledge.

Filippi M, Agosta F.

Curr Opin Neurol. 2018 Aug;31(4):405-414. doi: 10.1097/WCO.0000000000000571. Review.

PMID:
29746400
26.

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.

Bouwman F, Orini S, Gandolfo F, Altomare D, Festari C, Agosta F, Arbizu J, Drzezga A, Nestor P, Nobili F, Walker Z, Morbelli S, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1526-1533. doi: 10.1007/s00259-018-4034-z. Epub 2018 May 9.

27.

Changes in functional and structural brain connectome along the Alzheimer's disease continuum.

Filippi M, Basaia S, Canu E, Imperiale F, Magnani G, Falautano M, Comi G, Falini A, Agosta F.

Mol Psychiatry. 2020 Jan;25(1):230-239. doi: 10.1038/s41380-018-0067-8. Epub 2018 May 9.

PMID:
29743583
28.

Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

Nestor PJ, Altomare D, Festari C, Drzezga A, Rivolta J, Walker Z, Bouwman F, Orini S, Law I, Agosta F, Arbizu J, Boccardi M, Nobili F, Frisoni GB; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1509-1525. doi: 10.1007/s00259-018-4035-y. Epub 2018 May 7. Review.

PMID:
29736698
29.

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders.

Nobili F, Festari C, Altomare D, Agosta F, Orini S, Van Laere K, Arbizu J, Bouwman F, Drzezga A, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1557-1566. doi: 10.1007/s00259-018-4030-3. Epub 2018 May 2. Review.

PMID:
29721650
30.

Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease.

Agosta F, Altomare D, Festari C, Orini S, Gandolfo F, Boccardi M, Arbizu J, Bouwman F, Drzezga A, Nestor P, Nobili F, Walker Z, Pagani M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1546-1556. doi: 10.1007/s00259-018-4033-0. Epub 2018 May 1. Review.

PMID:
29717332
31.

Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Arbizu J, Festari C, Altomare D, Walker Z, Bouwman F, Rivolta J, Orini S, Barthel H, Agosta F, Drzezga A, Nestor P, Boccardi M, Frisoni GB, Nobili F; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1497-1508. doi: 10.1007/s00259-018-4039-7. Epub 2018 Apr 27. Review.

PMID:
29704037
32.

Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses.

Agosta F, Spinelli EG, Filippi M.

Expert Rev Neurother. 2018 May;18(5):395-406. doi: 10.1080/14737175.2018.1463160. Epub 2018 Apr 15. Review.

PMID:
29630421
33.

Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.

Stojkovic T, Stefanova E, Soldatovic I, Markovic V, Stankovic I, Petrovic I, Agosta F, Galantucci S, Filippi M, Kostic V.

J Neurol. 2018 Jun;265(6):1320-1327. doi: 10.1007/s00415-018-8838-3. Epub 2018 Mar 23.

PMID:
29572571
34.

Mirror therapy for an adult with central post-stroke pain: a case report.

Corbetta D, Sarasso E, Agosta F, Filippi M, Gatti R.

Arch Physiother. 2018 Feb 23;8:4. doi: 10.1186/s40945-018-0047-y. eCollection 2018.

35.
36.

Unraveling ALS due to SOD1 mutation through the combination of brain and cervical cord MRI.

Agosta F, Spinelli EG, Marjanovic IV, Stevic Z, Pagani E, Valsasina P, Salak-Djokic B, Jankovic M, Lavrnic D, Kostic VS, Filippi M.

Neurology. 2018 Feb 20;90(8):e707-e716. doi: 10.1212/WNL.0000000000005002. Epub 2018 Jan 24.

PMID:
29367447
37.

Tracking brain damage in progressive supranuclear palsy: a longitudinal MRI study.

Agosta F, Caso F, Ječmenica-Lukić M, Petrović IN, Valsasina P, Meani A, Copetti M, Kostić VS, Filippi M.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):696-701. doi: 10.1136/jnnp-2017-317443. Epub 2018 Jan 18.

PMID:
29348302
38.

Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism.

Caso F, Agosta F, Ječmenica-Lukić M, Petrović I, Meani A, Kostic VS, Filippi M.

Parkinsonism Relat Disord. 2018 Apr;49:95-99. doi: 10.1016/j.parkreldis.2018.01.001. Epub 2018 Jan 4.

PMID:
29336906
39.

Fast progressive lower motor neuron disease is an ALS variant: A two-centre tract of interest-based MRI data analysis.

Müller HP, Agosta F, Riva N, Spinelli EG, Comi G, Ludolph AC, Filippi M, Kassubek J.

Neuroimage Clin. 2017 Oct 14;17:145-152. doi: 10.1016/j.nicl.2017.10.008. eCollection 2018.

40.

Brain network connectivity differs in early-onset neurodegenerative dementia.

Filippi M, Basaia S, Canu E, Imperiale F, Meani A, Caso F, Magnani G, Falautano M, Comi G, Falini A, Agosta F.

Neurology. 2017 Oct 24;89(17):1764-1772. doi: 10.1212/WNL.0000000000004577. Epub 2017 Sep 27.

41.

Brain motor functional changes after somatosensory discrimination training.

Sarasso E, Agosta F, Temporiti F, Adamo P, Piccolo F, Copetti M, Gatti R, Filippi M.

Brain Imaging Behav. 2018 Aug;12(4):1011-1021. doi: 10.1007/s11682-017-9763-2.

PMID:
28861843
42.

TBK1 mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation.

Pozzi L, Valenza F, Mosca L, Dal Mas A, Domi T, Romano A, Tarlarini C, Falzone YM, Tremolizzo L, Sorarù G, Cerri F, Ferraro PM, Basaia S, Agosta F, Fazio R, Comola M, Comi G, Ferrari M, Quattrini A, Lunetta C, Penco S, Bonanomi D, Carrera P, Riva N.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):869-875. doi: 10.1136/jnnp-2017-316174. Epub 2017 Aug 19.

43.

Multimodal structural MRI in the diagnosis of motor neuron diseases.

Ferraro PM, Agosta F, Riva N, Copetti M, Spinelli EG, Falzone Y, Sorarù G, Comi G, Chiò A, Filippi M.

Neuroimage Clin. 2017 Aug 2;16:240-247. doi: 10.1016/j.nicl.2017.08.002. eCollection 2017.

44.

White matter tract alterations in Parkinson's disease patients with punding.

Canu E, Agosta F, Markovic V, Petrovic I, Stankovic I, Imperiale F, Stojkovic T, Copetti M, Kostic VS, Filippi M.

Parkinsonism Relat Disord. 2017 Oct;43:85-91. doi: 10.1016/j.parkreldis.2017.07.025. Epub 2017 Jul 27.

PMID:
28780181
45.

Structural and functional brain signatures of C9orf72 in motor neuron disease.

Agosta F, Ferraro PM, Riva N, Spinelli EG, Domi T, Carrera P, Copetti M, Falzone Y, Ferrari M, Lunetta C, Comi G, Falini A, Quattrini A, Filippi M.

Neurobiol Aging. 2017 Sep;57:206-219. doi: 10.1016/j.neurobiolaging.2017.05.024. Epub 2017 Jun 6.

PMID:
28666709
46.

Multiparametric MRI to distinguish early onset Alzheimer's disease and behavioural variant of frontotemporal dementia.

Canu E, Agosta F, Mandic-Stojmenovic G, Stojković T, Stefanova E, Inuggi A, Imperiale F, Copetti M, Kostic VS, Filippi M.

Neuroimage Clin. 2017 May 25;15:428-438. doi: 10.1016/j.nicl.2017.05.018. eCollection 2017.

47.

Role of habenula and amygdala dysfunction in Parkinson disease patients with punding.

Markovic V, Agosta F, Canu E, Inuggi A, Petrovic I, Stankovic I, Imperiale F, Stojkovic T, Kostic VS, Filippi M.

Neurology. 2017 Jun 6;88(23):2207-2215. doi: 10.1212/WNL.0000000000004012. Epub 2017 May 10.

PMID:
28490656
48.

Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's disease.

Imperiale F, Agosta F, Canu E, Markovic V, Inuggi A, Jecmenica-Lukic M, Tomic A, Copetti M, Basaia S, Kostic VS, Filippi M.

Mol Psychiatry. 2018 Feb;23(2):459-466. doi: 10.1038/mp.2017.18. Epub 2017 Mar 7.

PMID:
28265121
49.

Typical and atypical pathology in primary progressive aphasia variants.

Spinelli EG, Mandelli ML, Miller ZA, Santos-Santos MA, Wilson SM, Agosta F, Grinberg LT, Huang EJ, Trojanowski JQ, Meyer M, Henry ML, Comi G, Rabinovici G, Rosen HJ, Filippi M, Miller BL, Seeley WW, Gorno-Tempini ML.

Ann Neurol. 2017 Mar;81(3):430-443. doi: 10.1002/ana.24885. Epub 2017 Mar 20.

50.

Structural Brain Connectome and Cognitive Impairment in Parkinson Disease.

Galantucci S, Agosta F, Stefanova E, Basaia S, van den Heuvel MP, Stojković T, Canu E, Stanković I, Spica V, Copetti M, Gagliardi D, Kostić VS, Filippi M.

Radiology. 2017 May;283(2):515-525. doi: 10.1148/radiol.2016160274. Epub 2016 Dec 7.

PMID:
27924721

Supplemental Content

Loading ...
Support Center